We are live on ! Find out more
NED

Nancy E. Dempze Portfolio holdings

AUM $182M
1-Year Est. Return 16.09%
This Fund
S&P 500
This Quarter Est. Return
+2.73%
1 Year Est. Return
+16.09%
3 Year Est. Return
+59.1%
5 Year Est. Return
+78.95%
10 Year Est. Return
+300.76%
AUM
$81.8M
AUM Growth
+$703K
Cap. Flow
-$885K
Cap. Flow %
-1.08%
Top 10 Hldgs %
36.28%
Holding
81
New
2
Increased
21
Reduced
26
Closed
5

Top Buys

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$320K
2
CELG
Celgene Corp
CELG
+$209K
3
DD icon
DuPont de Nemours
DD
+$205K
4
CNI icon
Canadian National Railway
CNI
+$171K
5
MMM icon
3M
MMM
+$135K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$290K
2
PH icon
Parker-Hannifin
PH
+$272K
3
MA icon
Mastercard
MA
+$225K
4
NXPI icon
NXP Semiconductors
NXPI
+$208K
5
CSCO icon
Cisco
CSCO
+$205K

Sector Composition

Rank Sector Weight
1 Healthcare 23.96%
2 Technology 21.53%
3 Industrials 15.1%
4 Financials 10.57%
5 Consumer Staples 7.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLNX
26
DELISTED
Xilinx Inc
XLNX
$1.06M 1.3%
16,309
-184
-1% -$12.5K
FTV icon
27
Fortive
FTV
$18B
$968K 1.18%
19,893
+1,420
+8% +$67.8K
XOM icon
28
ExxonMobil
XOM
$650B
$842K 1.03%
10,158
+155
+2% +$12.3K
CELG
29
DELISTED
Celgene Corp
CELG
$803K 0.98%
10,094
+2,520
+33% +$209K
JPM icon
30
JPMorgan Chase
JPM
$916B
$703K 0.86%
6,745
– –
V icon
31
Visa
V
$677B
$645K 0.79%
4,870
– –
GILD icon
32
Gilead Sciences
GILD
$165B
$579K 0.71%
8,166
+598
+8% +$42.2K
MRK icon
33
Merck
MRK
$322B
$564K 0.69%
9,730
-5,139
-35% -$290K
SPY icon
34
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$543K 0.66%
2,000
-400
-17% -$108K
TJX icon
35
TJX Companies
TJX
$179B
$517K 0.63%
10,848
– –
DIS icon
36
Walt Disney
DIS
$171B
$512K 0.63%
4,883
-500
-9% -$51.1K
BRK.B icon
37
Berkshire Hathaway Class B
BRK.B
$1.1T
$496K 0.61%
2,658
– –
ORCL icon
38
Oracle
ORCL
$339B
$493K 0.6%
11,196
-2,725
-20% -$126K
GOOG icon
39
Alphabet (Google) Class C
GOOG
$4.11T
$491K 0.6%
8,800
– –
PEP icon
40
PepsiCo
PEP
$196B
$480K 0.59%
4,400
-1,360
-24% -$140K
ITW icon
41
Illinois Tool Works
ITW
$84.1B
$472K 0.58%
3,415
-155
-4% -$22.9K
UNP icon
42
Union Pacific
UNP
$174B
$456K 0.56%
3,220
-90
-3% -$12.5K
CL icon
43
Colgate-Palmolive
CL
$74.8B
$446K 0.55%
6,880
+1,110
+19% +$72.6K
CHD icon
44
Church & Dwight Co
CHD
$23.7B
$430K 0.53%
8,100
– –
ABBV icon
45
AbbVie
ABBV
$465B
$408K 0.5%
4,400
-260
-6% -$25.4K
BDX icon
46
Becton Dickinson
BDX
$46.4B
$407K 0.5%
1,743
– –
MTD icon
47
Mettler-Toledo International
MTD
$28.1B
$405K 0.5%
700
– –
IPGP icon
48
IPG Photonics
IPGP
$3.4B
$386K 0.47%
1,749
-30
-2% -$7.08K
BIIB icon
49
Biogen
BIIB
$30.9B
$348K 0.43%
1,200
– –
EMR icon
50
Emerson Electric
EMR
$81.6B
$342K 0.42%
4,960
– –
1
2
3

Similar funds

RS
R Squared Central, Hong Kong $182M AUM 18.52% 1-Year Est. Return
CFG
Cosner Financial Group Windsor, Colorado $182M AUM 12.93% 1-Year Est. Return
CFG
Capital Financial Group Greenwood Village, Colorado $182M AUM
TFP
Tilia Fiduciary Partners Wilmington, North Carolina $182M AUM 18.85% 1-Year Est. Return
AFS
Anderson Financial Strategies Dayton, Ohio $182M AUM 13.12% 1-Year Est. Return
EMB
Elefante Mark B $182M AUM 17.71% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
HWM
HFG Wealth Management The Woodlands, Texas $182M AUM 14.4% 1-Year Est. Return

Nancy E. Dempze's Q2 2018 Portfolio in Review

As of Q2 2018, Nancy E. Dempze held 81 positions worth $81.8M, up 0.87% from $81.1M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Nancy E. Dempze's Q2 2018 filing shows 2 new, 21 increased, 26 reduced and 5 closed positions. Its largest new stake was PayPal: 4,015 shares worth $334K. The largest sale was Merck, an estimated $290K.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

  • Nancy E. Dempze's largest Q2 2018 buy was PayPal: 4,015 shares worth $334K.
  • Nancy E. Dempze added most to Celgene Corp in Q2 2018, an estimated $209K increase.
  • Nancy E. Dempze's biggest Q2 2018 reduction was Merck, cutting an estimated $290K.
  • Nancy E. Dempze fully exited Parker-Hannifin in Q2 2018, selling an estimated $272K.
  • Nancy E. Dempze's ten largest holdings make up 36% of its $81.8M portfolio in Q2 2018.
  • Nancy E. Dempze opened 2 new positions and closed 5 in Q2 2018.
  • Nancy E. Dempze's portfolio value rose 0.87% quarter-over-quarter to $81.8M.

Based on Nancy E. Dempze's 13F filing for Q2 2018, filed 30 Jul 2018.